Dendritic cell research a step toward improved vaccines, immune health

March 19, 2014 by Sarah Zobel
Eyal Amiel is making discoveries about how the immune system works on the cellular level -- research that could improve vaccine design. Credit: Sally McCay

(Medical Xpress)—Eyal Amiel didn't think he wanted to study immunology, let alone make a career of it. But as co-author of a paper recently published in the journal Nature Immunology, Amiel, assistant professor in the Department of Medical Laboratory and Radiation Science in the College of Nursing and Health Sciences, is at the forefront of research that could eventually lead to changes in vaccine design, along with new approaches to treating immune-related diseases.

The paper's focus is on dendritic , which are critical to the ; their function is to process antibody-generating materials, or antigens, and present them to T cells, which then shape the immune response. The paper considers the cellular upregulation of glucose, which maintains a cell's energy but also creates fatty acids that are secreted by the cell as part of its . Together with his colleagues, headed by lead author Bart Everts, Amiel determined that the early consumption of glucose is vital to the activation of cells, in terms of the production and secretion of proteins that are essential to the cells' .

Amiel is already bringing the paper's findings from mouse to human, having spearheaded a memorandum of understanding with the Champlain Valley Physicians' Hospital in Plattsburgh, N.Y., which will provide his lab with human blood cell filters, a waste product. The lab will reverse flush the out and fill them with cultures, allowing them to make new observations about the in humans.

In retrospect, says Amiel, his initial resistance to entering the field was unfounded. As an undergraduate at Amherst College, the native of Israel, who had moved to the United States at age 4 and to Walden, Vt., at age 7, rejected the suggestion made by his academic advisor—who also taught immunology—that Amiel enroll in his course. With a focus on genetics, in particular slime mold, an organism that allowed him to study developmental regulation, Amiel would go on to graduate with a double major in biology and philosophy. The latter is evident in his ongoing ethical concern with using mice in his work, though he acknowledges that it's a common struggle, and that there's no real alternative as yet.

When he landed a job as a research technician at Dartmouth College, Amiel was surprised to find himself in the immunology laboratory, where he spent two years using his genetics expertise to profile the regulation of immunology genes. It was then, he says, that he realized that although basic science for science's sake is important, "you have to justify the dollars spent in a way that makes sense for medical relevance, and the bettering of our society. Immunology is an easy subfield to do that."

He stayed at Dartmouth to earn a doctorate in microbiology and immunology, where his work focused on the two categories of receptors and the relationship between them—signaling cells, essentially the "on" switch to the cell's immune protection program, and recognition molecules that facilitate the engulfment of bacteria—and how they cooperate to bring bacteria to the surface. In a nutshell, he found that if you take away some of the interactions between the two, you can "push that fine balance of the immune system into problem areas like sepsis," he says.

At New York's Saranac Lake–based Trudeau Institute, Amiel undertook a postdoc project with Ed Pearce, in which he studied the metabolic regulation of dendritic cell activity. When dendritic cells are activated, they undergo fundamental changes in their use of nutrients, increasing dependence on sugar consumption. Specifically, he wanted to gain a fundamental understanding of why cells change their metabolism when they're activated, whether that is necessary for their activation and what happens if it is modulated. The paper is one outcome.

"The power of these questions is that if we can understand the metabolic switch in both directions," Amiel says, "then we could increase immune activity where we might want to—in, say, vaccines—or we could dampen it where that would be advantageous, as in autoimmune disease or hyper-inflammatory conditions where it's toxic."

Together with his wife—a Cabot native—and their infant daughter, Amiel arrived at UVM last August, drawn by the university's "broad array of resources and opportunities for cross-departmental research collaborations." In addition to running a lab, with one technician, a grad student, and six undergraduates, he is, he notes with a touch of irony, teaching undergraduate immunology.

As of early March, Amiel is also an affiliate member of the Vermont Cancer Center. In February, he received a patent for a method of producing activated antigen presenting cells and potential methods of using them in anti-cancer vaccines. He's looked at the application of dendritic cells on a melanoma model in mice, and his lab is beginning research into glutamine, which shares many properties with glucose, but may be more important in governing what cells do.

One finding Amiel's lab has made is that the activation of dendritic cells means a shortening of their lifespan, which they've determined is metabolically linked. By manipulating key metabolic pathways, Amiel says, they can toy with their activation and cell survival, something that could result in that have both longer lives and bigger immune responses than their normal counterparts, and would therefore be beneficial in mounting an to a tumor.

"The immune system is constantly riding that fine line between how much protection we can have without too much collateral damage," Amiel says, noting that the system is based on being toxic to the non-self. "It's really that fine line that makes immunology so interesting."

Explore further: Immunology researchers uncover pathways that direct immune system to turn 'on' or 'off'

More information: "TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation." Bart Everts, et al. Nature Immunology (2014) DOI: 10.1038/ni.2833 . Received 03 October 2013 Accepted 24 January 2014 Published online 23 February 2014

Related Stories

Immunology researchers uncover pathways that direct immune system to turn 'on' or 'off'

March 18, 2014
(Medical Xpress)—A key discovery explaining how components of the immune system determine whether to activate or to suppress the immune system, made by Kelvin Lee, MD, Professor of Oncology and Co-Leader of the Tumor Immunology ...

Researchers discover how cancer 'invisibility cloak' works

October 28, 2013
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, ...

Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

March 5, 2014
A novel approach to cancer immunotherapy – strategies designed to induce the immune system to attack cancer cells – may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian ...

Bacteria may assist the immune system response against cancer

March 3, 2014
(Medical Xpress)—Recent research from the University of Otago shows that bacteria may assist the body's immune system response against cancer cells and help fight tumours like melanoma.

Modified immune cells seek and destroy melanoma

June 24, 2013
In this issue of the Journal of Clinical Investigation, researchers led by Scott Pruitt at Duke University and Merck Research Laboratories report on a human clinical trial in which modified dendritic cells, a component of ...

Researchers find promising results with local hyperthermia of tumors

March 4, 2014
A combination of iron-oxide nanoparticles and an alternating magnetic field, which together generate heat, have activated an immune system response to tumors in mice according to an accepted manuscript by Dartmouth-Hitchcock ...

Recommended for you

Researchers release the brakes on the immune system

October 18, 2017
Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism that normally prevent an excessive immune response. Researchers at the ...

Gene transcription in virus-specific CD8 T cells differentiates chronic from resolving HCV

October 17, 2017
Massachusetts General Hospital (MGH) investigators have identified differences in gene transcription within key immune cells that may distinguish those individuals infected with the hepatitis C virus (HCV) who develop chronic ...

How cytoplasmic DNA triggers inflammation in human cells

October 17, 2017
A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...

Early trials show potential for treating hay fever with grass protein fragments

October 13, 2017
Protein fragments taken from grass can help protect hay fever patients from allergic reactions to pollen grains.

Researchers find mechanism for precise targeting of the immune response

October 13, 2017
The immune system checks the health of cells by examining a kind of molecular passport. Sometimes, cells present the wrong passport, which can lead to autoimmune diseases, chronic inflammations or cancer. Scientists of the ...

Enzyme behind immune cell response revealed

October 12, 2017
Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body. Moreover, they suggest that the enzyme may be a potential target for drug development ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.